strategic alternatives
Top Five Articles on 360Dx Last Week: Talis Biomedical Layoffs; PAMA Implementation Delay; More
Last week, readers were most interested in a story about layoffs at Talis Biomedical as the company plans to explore strategic alternatives.
Talis Biomedical Lays Off 90 Percent of Workforce, Will Explore Strategic Alternatives
The company's board of directors has appointed a special committee of independent directors to consider a range of strategic alternatives.
Shareholder Calls on Cue Health to Begin Strategic Review, Realign Costs
The shareholder, Tarsadia Investments, noted concerns about Cue's cost structure and future business plans.
Enzo Biochem Fiscal Q3 Revenues Fall 20 Percent; Firm Examining Strategic Alternatives
Enzo has engaged investment bank Jefferies to evaluate strategic alternatives for the company and its various divisions and assets.
OraSure Misses COVID-19 Antigen Test Sales Guidance; Announces CEO Departure, Strategic Review
OraSure expects to miss its full-year rapid COVID-19 antigen test sales estimate by $10 million, and will now undertake a strategic review.
Jun 10, 2019
Enzo Biochem Fiscal Q3 Revenues Decline 22 Percent
Nov 8, 2018
Akers Biosciences Announces Strategic Review
Apr 2, 2018